Tavazoie Sohail F, Alarcón Claudio, Oskarsson Thordur, Padua David, Wang Qiongqing, Bos Paula D, Gerald William L, Massagué Joan
Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Nature. 2008 Jan 10;451(7175):147-52. doi: 10.1038/nature06487.
A search for general regulators of cancer metastasis has yielded a set of microRNAs for which expression is specifically lost as human breast cancer cells develop metastatic potential. Here we show that restoring the expression of these microRNAs in malignant cells suppresses lung and bone metastasis by human cancer cells in vivo. Of these microRNAs, miR-126 restoration reduces overall tumour growth and proliferation, whereas miR-335 inhibits metastatic cell invasion. miR-335 regulates a set of genes whose collective expression in a large cohort of human tumours is associated with risk of distal metastasis. miR-335 suppresses metastasis and migration through targeting of the progenitor cell transcription factor SOX4 and extracellular matrix component tenascin C. Expression of miR-126 and miR-335 is lost in the majority of primary breast tumours from patients who relapse, and the loss of expression of either microRNA is associated with poor distal metastasis-free survival. miR-335 and miR-126 are thus identified as metastasis suppressor microRNAs in human breast cancer.
对癌症转移的一般调节因子进行的研究已经产生了一组微小RNA,随着人类乳腺癌细胞获得转移潜能,这些微小RNA的表达会特异性丧失。我们在此表明,在恶性细胞中恢复这些微小RNA的表达可在体内抑制人类癌细胞的肺转移和骨转移。在这些微小RNA中,恢复miR-126的表达可降低肿瘤的总体生长和增殖,而miR-335则抑制转移细胞侵袭。miR-335调控一组基因,这些基因在大量人类肿瘤中的共同表达与远处转移风险相关。miR-335通过靶向祖细胞转录因子SOX4和细胞外基质成分肌腱蛋白C来抑制转移和迁移。在复发患者的大多数原发性乳腺肿瘤中miR-126和miR-335的表达缺失,并且任一微小RNA表达的缺失都与较差的无远处转移生存率相关。因此,miR-335和miR-126被确定为人类乳腺癌中的转移抑制微小RNA。